Literature DB >> 10225836

Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis.

V L Motin1, L M de la Maza, E M Peterson.   

Abstract

C3H (H-2(k)) mice are susceptible to a vaginal challenge with human strains of Chlamydia trachomatis and thus are a useful strain for testing potential Chlamydia vaccine candidates. However, C3H mice are fairly poor responders in terms of the level of antibody resulting from immunization with potential protective peptides representing variable domains (VDs) of the major outer membrane protein (MOMP). C57BL/6 (H-2(b)) mice, on the other hand, are moderately resistant to a vaginal challenge but are good responders to the chlamydial MOMP VDs. Peptides representing universal T-cell helper epitopes were employed to determine whether the antibody response to a peptide representing VD4 of the MOMP, which has been shown to contain neutralizing epitopes, could be enhanced in C3H and C57 mice. Universal T-cell helper peptides from tetanus toxin, the pre-S2 region of hepatitis B virus, and the mouse heat shock protein 60, as well as the corresponding segment of the Chlamydia heat shock protein 60 (hspct), were coadministered with the VD4 peptide. Peptides were coencapsulated in liposomes containing the adjuvant monophosphoryl lipid A and administered by using a combination of mucosal and intramuscular injection. The only T-cell helper peptide that improved the immune response as judged by antibody level, in vitro neutralization assays, and T-cell proliferation was hspct. The response in the C57BL/6 strain was not significantly enhanced with hspct over levels achieved with VD4 alone; however, in C3H mice the levels of serum antibody to C. trachomatis increased to that seen in C57 mice. However, the molecular specificity and immunoglobulin subclass distribution differed from those of the C57 response, and the neutralizing titers and T-cell proliferation responses were lower. In both strains of mice, titers of vaginal antibody to C. trachomatis were low. In summary, of the T-helper peptides used, only hspct significantly enhanced the immune response of C3H mice to the VD4 peptide, but it had only a modest effect on the immune response of C57 mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10225836      PMCID: PMC103723          DOI: 10.1128/CDLI.6.3.356-363.1999

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  36 in total

1.  Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.

Authors:  T Darville; C W Andrews; K K Laffoon; W Shymasani; L R Kishen; R G Rank
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

2.  Diversity of Chlamydia trachomatis major outer membrane protein genes.

Authors:  R S Stephens; R Sanchez-Pescador; E A Wagar; C Inouye; M S Urdea
Journal:  J Bacteriol       Date:  1987-09       Impact factor: 3.490

3.  Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma.

Authors:  R W Peeling; R L Bailey; D J Conway; M J Holland; A E Campbell; O Jallow; H C Whittle; D C Mabey
Journal:  J Infect Dis       Date:  1998-01       Impact factor: 5.226

4.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

5.  Antigenic analysis of the major outer membrane protein of Chlamydia spp.

Authors:  H D Caldwell; J Schachter
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

6.  Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.

Authors:  L M de la Maza; S Pal; A Khamesipour; E M Peterson
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.

Authors:  H Su; M Parnell; H D Caldwell
Journal:  Vaccine       Date:  1995-08       Impact factor: 3.641

8.  An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen, Chlamydia trachomatis.

Authors:  J E Allen; R S Stephens
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

9.  Overview of Chlamydia trachomatis infection and the requirements for a vaccine.

Authors:  J Schachter
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec

10.  Self and foreign 60-kilodalton heat shock protein T cell epitope peptides serve as immunogenic carriers for a T cell-independent sugar antigen.

Authors:  S Könen-Waisman; M Fridkin; I R Cohen
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

View more
  2 in total

1.  A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.

Authors:  Sukumar Pal; Olga V Tatarenkova; Luis M de la Maza
Journal:  Immunology       Date:  2015-10-01       Impact factor: 7.397

2.  Assessment of the role in protection and pathogenesis of the Chlamydia muridarum V-type ATP synthase subunit A (AtpA) (TC0582).

Authors:  Chunmei Cheng; Pooja Jain; Sukumar Pal; Delia Tifrea; Guifeng Sun; Andy A Teng; Xiaowu Liang; Philip L Felgner; Luis M de la Maza
Journal:  Microbes Infect       Date:  2013-10-23       Impact factor: 2.700

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.